Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 34 entries
Sorted by: Best Match Show Resources per page
Fibroids and Infertility.

Current obstetrics and gynecology reports

Purohit P, Vigneswaran K.
PMID: 27217980
Curr Obstet Gynecol Rep. 2016;5:81-88. doi: 10.1007/s13669-016-0162-2. Epub 2016 Apr 25.

The precise impact of fibroids, which are the most common benign gynaecological tumours in women, on reproductive function and infertility is unknown. The need to treat submucosal fibroids is widely accepted, but fibroids in other locations and sizes continue...

Cite
Purohit P, Vigneswaran K. Fibroids and Infertility. Curr Obstet Gynecol Rep. 2016;5:81-88doi: 10.1007/s13669-016-0162-2.
Purohit, P., & Vigneswaran, K. (2016). Fibroids and Infertility. Current obstetrics and gynecology reports, 581-88. https://doi.org/10.1007/s13669-016-0162-2
Purohit, P, and Vigneswaran, K. "Fibroids and Infertility." Current obstetrics and gynecology reports vol. 5 (2016): 81-88. doi: https://doi.org/10.1007/s13669-016-0162-2
Purohit P, Vigneswaran K. Fibroids and Infertility. Curr Obstet Gynecol Rep. 2016;5:81-88. doi: 10.1007/s13669-016-0162-2. Epub 2016 Apr 25. PMID: 27217980; PMCID: PMC4859843.
Copy Download .nbib Format: NLM
An Evidence-Based Approach to the Evaluation, Diagnostic Assessment and Treatment of Fecal Incontinence in Women.

Current obstetrics and gynecology reports

Meyer I, Richter HE.
PMID: 25505643
Curr Obstet Gynecol Rep. 2014 Sep;3(3):155-164. doi: 10.1007/s13669-014-0085-8.

Fecal incontinence (FI) is a debilitating disorder which negatively impacts quality of life. The etiology is often multifactorial and although most women with FI are able to be treated, many remain untreated because a significant proportion of women do...

Cite
Meyer I, Richter HE. An Evidence-Based Approach to the Evaluation, Diagnostic Assessment and Treatment of Fecal Incontinence in Women. Curr Obstet Gynecol Rep. 2014;3(3):155-164doi: 10.1007/s13669-014-0085-8.
Meyer, I., & Richter, H. E. (2014). An Evidence-Based Approach to the Evaluation, Diagnostic Assessment and Treatment of Fecal Incontinence in Women. Current obstetrics and gynecology reports, 3(3), 155-164. https://doi.org/10.1007/s13669-014-0085-8
Meyer, Isuzu, and Richter, Holly E. "An Evidence-Based Approach to the Evaluation, Diagnostic Assessment and Treatment of Fecal Incontinence in Women." Current obstetrics and gynecology reports vol. 3,3 (2014): 155-164. doi: https://doi.org/10.1007/s13669-014-0085-8
Meyer I, Richter HE. An Evidence-Based Approach to the Evaluation, Diagnostic Assessment and Treatment of Fecal Incontinence in Women. Curr Obstet Gynecol Rep. 2014 Sep;3(3):155-164. doi: 10.1007/s13669-014-0085-8. PMID: 25505643; PMCID: PMC4258837.
Copy Download .nbib Format: NLM
Obesity Education Strategies for Cancer Prevention in Women's Health.

Current obstetrics and gynecology reports

Liu L, Segura A, Hagemann AR.
PMID: 26877893
Curr Obstet Gynecol Rep. 2015 Dec 01;4(4):249-258. doi: 10.1007/s13669-015-0129-8. Epub 2015 Oct 13.

Obesity is the cause of up to one-third of all cancers affecting women today, most notably endometrial, colon and breast cancer. Women's health providers are poised to advise women on obesity's link to cancer development, but often lack resources...

Cite
Liu L, Segura A, Hagemann AR. Obesity Education Strategies for Cancer Prevention in Women's Health. Curr Obstet Gynecol Rep. 2015;4(4):249-258doi: 10.1007/s13669-015-0129-8.
Liu, L., Segura, A., & Hagemann, A. R. (2015). Obesity Education Strategies for Cancer Prevention in Women's Health. Current obstetrics and gynecology reports, 4(4), 249-258. https://doi.org/10.1007/s13669-015-0129-8
Liu, Lucy, et al. "Obesity Education Strategies for Cancer Prevention in Women's Health." Current obstetrics and gynecology reports vol. 4,4 (2015): 249-258. doi: https://doi.org/10.1007/s13669-015-0129-8
Liu L, Segura A, Hagemann AR. Obesity Education Strategies for Cancer Prevention in Women's Health. Curr Obstet Gynecol Rep. 2015 Dec 01;4(4):249-258. doi: 10.1007/s13669-015-0129-8. Epub 2015 Oct 13. PMID: 26877893; PMCID: PMC4749264.
Copy Download .nbib Format: NLM
Ovarian Cancer Is an Imported Disease: Fact or Fiction?.

Current obstetrics and gynecology reports

Kuhn E, Kurman RJ, Shih IM.
PMID: 22506137
Curr Obstet Gynecol Rep. 2012 Mar;1(1):1-9. doi: 10.1007/s13669-011-0004-1.

The cell of origin of ovarian cancer has been long debated. The current paradigm is that epithelial ovarian cancer (EOC) arises from the ovarian surface epithelium (OSE). OSE is composed of flat, nondescript cells more closely resembling the mesothelium...

Cite
Kuhn E, Kurman RJ, Shih IM. Ovarian Cancer Is an Imported Disease: Fact or Fiction?. Curr Obstet Gynecol Rep. 2012;1(1):1-9doi: 10.1007/s13669-011-0004-1.
Kuhn, E., Kurman, R. J., & Shih, I. M. (2012). Ovarian Cancer Is an Imported Disease: Fact or Fiction?. Current obstetrics and gynecology reports, 1(1), 1-9. https://doi.org/10.1007/s13669-011-0004-1
Kuhn, Elisabetta, et al. "Ovarian Cancer Is an Imported Disease: Fact or Fiction?." Current obstetrics and gynecology reports vol. 1,1 (2012): 1-9. doi: https://doi.org/10.1007/s13669-011-0004-1
Kuhn E, Kurman RJ, Shih IM. Ovarian Cancer Is an Imported Disease: Fact or Fiction?. Curr Obstet Gynecol Rep. 2012 Mar;1(1):1-9. doi: 10.1007/s13669-011-0004-1. PMID: 22506137; PMCID: PMC3322388.
Copy Download .nbib Format: NLM
Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease.

Current obstetrics and gynecology reports

Ngu SF, Chan KK.
PMID: 24533232
Curr Obstet Gynecol Rep. 2014 Jan 04;3:84-90. doi: 10.1007/s13669-013-0071-6. eCollection 2014.

Gestational trophoblastic neoplasia (GTN) is highly chemosensitive and has a high cure rate. Since the introduction of chemotherapy, reliable measurement of human chorionic gonadotropin (hCG) levels, and individualised risk-based therapy into the management of GTN, almost all low-risk and...

Cite
Ngu SF, Chan KK. Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease. Curr Obstet Gynecol Rep. 2014;3:84-90doi: 10.1007/s13669-013-0071-6.
Ngu, S. F., & Chan, K. K. (2014). Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease. Current obstetrics and gynecology reports, 384-90. https://doi.org/10.1007/s13669-013-0071-6
Ngu, Siew-Fei, and Chan, Karen K L. "Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease." Current obstetrics and gynecology reports vol. 3 (2014): 84-90. doi: https://doi.org/10.1007/s13669-013-0071-6
Ngu SF, Chan KK. Management of Chemoresistant and Quiescent Gestational Trophoblastic Disease. Curr Obstet Gynecol Rep. 2014 Jan 04;3:84-90. doi: 10.1007/s13669-013-0071-6. eCollection 2014. PMID: 24533232; PMCID: PMC3920061.
Copy Download .nbib Format: NLM
Endometriosis: Epidemiology, Diagnosis and Clinical Management.

Current obstetrics and gynecology reports

Parasar P, Ozcan P, Terry KL.
PMID: 29276652
Curr Obstet Gynecol Rep. 2017 Mar;6(1):34-41. doi: 10.1007/s13669-017-0187-1. Epub 2017 Jan 27.

PURPOSE OF REVIEW: Endometriosis is a disease of adolescents and reproductive-aged women characterized by the presence of endometrial tissue outside the uterine cavity and commonly associated with chronic pelvic pain and infertility. Here we review the epidemiology of endometriosis...

Cite
Parasar P, Ozcan P, Terry KL. Endometriosis: Epidemiology, Diagnosis and Clinical Management. Curr Obstet Gynecol Rep. 2017;6(1):34-41doi: 10.1007/s13669-017-0187-1.
Parasar, P., Ozcan, P., & Terry, K. L. (2017). Endometriosis: Epidemiology, Diagnosis and Clinical Management. Current obstetrics and gynecology reports, 6(1), 34-41. https://doi.org/10.1007/s13669-017-0187-1
Parasar, Parveen, et al. "Endometriosis: Epidemiology, Diagnosis and Clinical Management." Current obstetrics and gynecology reports vol. 6,1 (2017): 34-41. doi: https://doi.org/10.1007/s13669-017-0187-1
Parasar P, Ozcan P, Terry KL. Endometriosis: Epidemiology, Diagnosis and Clinical Management. Curr Obstet Gynecol Rep. 2017 Mar;6(1):34-41. doi: 10.1007/s13669-017-0187-1. Epub 2017 Jan 27. PMID: 29276652; PMCID: PMC5737931.
Copy Download .nbib Format: NLM
A High-Strength, Absorbable, Antibacterial Knotless Tissue Control Device for Fascial Closure.

Current obstetrics and gynecology reports

Nawrocki JG, Nonnenmann H, Mooney M, Sutton N, Schmitz ND.
PMID: 28603661
Curr Obstet Gynecol Rep. 2017;6(2):175-181. doi: 10.1007/s13669-017-0208-0. Epub 2017 May 06.

PURPOSE OF REVIEW: This review provides an overview of the STRATAFIX™ SYMMETRIC PDS™ Plus Knotless Tissue Control Device design and performance characteristics and highlights the device's relevance for use in gynecological procedures. Various device testing was conducted on tensile...

Cite
Nawrocki JG, Nonnenmann H, Mooney M, et al. A High-Strength, Absorbable, Antibacterial Knotless Tissue Control Device for Fascial Closure. Curr Obstet Gynecol Rep. 2017;6(2):175-181doi: 10.1007/s13669-017-0208-0.
Nawrocki, J. G., Nonnenmann, H., Mooney, M., Sutton, N., & Schmitz, N. D. (2017). A High-Strength, Absorbable, Antibacterial Knotless Tissue Control Device for Fascial Closure. Current obstetrics and gynecology reports, 6(2), 175-181. https://doi.org/10.1007/s13669-017-0208-0
Nawrocki, Jesse G, et al. "A High-Strength, Absorbable, Antibacterial Knotless Tissue Control Device for Fascial Closure." Current obstetrics and gynecology reports vol. 6,2 (2017): 175-181. doi: https://doi.org/10.1007/s13669-017-0208-0
Nawrocki JG, Nonnenmann H, Mooney M, Sutton N, Schmitz ND. A High-Strength, Absorbable, Antibacterial Knotless Tissue Control Device for Fascial Closure. Curr Obstet Gynecol Rep. 2017;6(2):175-181. doi: 10.1007/s13669-017-0208-0. Epub 2017 May 06. PMID: 28603661; PMCID: PMC5442192.
Copy Download .nbib Format: NLM
Natural History of Uterine Fibroids: A Radiological Perspective.

Current obstetrics and gynecology reports

Ghosh S, Naftalin J, Imrie R, Hoo WL.
PMID: 30101039
Curr Obstet Gynecol Rep. 2018;7(3):117-121. doi: 10.1007/s13669-018-0243-5. Epub 2018 May 08.

PURPOSE OF REVIEW: This review aims to update our understanding of the radiological life cycle of fibroids, so that we may better counsel patients making difficult treatment decisions. Evidence for both pregnant and non-pregnant women have been considered separately.RECENT...

Cite
Ghosh S, Naftalin J, Imrie R, et al. Natural History of Uterine Fibroids: A Radiological Perspective. Curr Obstet Gynecol Rep. 2018;7(3):117-121doi: 10.1007/s13669-018-0243-5.
Ghosh, S., Naftalin, J., Imrie, R., & Hoo, W. L. (2018). Natural History of Uterine Fibroids: A Radiological Perspective. Current obstetrics and gynecology reports, 7(3), 117-121. https://doi.org/10.1007/s13669-018-0243-5
Ghosh, Srirupa, et al. "Natural History of Uterine Fibroids: A Radiological Perspective." Current obstetrics and gynecology reports vol. 7,3 (2018): 117-121. doi: https://doi.org/10.1007/s13669-018-0243-5
Ghosh S, Naftalin J, Imrie R, Hoo WL. Natural History of Uterine Fibroids: A Radiological Perspective. Curr Obstet Gynecol Rep. 2018;7(3):117-121. doi: 10.1007/s13669-018-0243-5. Epub 2018 May 08. PMID: 30101039; PMCID: PMC6060784.
Copy Download .nbib Format: NLM
Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells.

Current obstetrics and gynecology reports

Pin-Jung C, Pai-Chi T, Zhu Y, Jen Jan Y, Smalley M, Afshar Y, Li-Ching C, Pisarska MD, Hsian-Rong T.
PMID: 31565541
Curr Obstet Gynecol Rep. 2019 Mar;8(1):1-8. Epub 2019 Jan 21.

PURPOSE OF REVIEW: The purpose of this review is to highlight recent research advances in noninvasive prenatal diagnostic methods.RECENT FINDINGS: Recent studies developing noninvasive prenatal diagnostic (NIPD) methods have been focused on either fetal nucleated red blood cells (fNRBCs)...

Cite
Pin-Jung C, Pai-Chi T, Zhu Y, et al. Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells. Curr Obstet Gynecol Rep. 2019;8(1):1-8
Pin-Jung, C., Pai-Chi, T., Zhu, Y., Jen Jan, Y., Smalley, M., Afshar, Y., Li-Ching, C., Pisarska, M. D., & Hsian-Rong, T. (2019). Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells. Current obstetrics and gynecology reports, 8(1), 1-8.
Pin-Jung, Chen, et al. "Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells." Current obstetrics and gynecology reports vol. 8,1 (2019): 1-8.
Pin-Jung C, Pai-Chi T, Zhu Y, Jen Jan Y, Smalley M, Afshar Y, Li-Ching C, Pisarska MD, Hsian-Rong T. Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells. Curr Obstet Gynecol Rep. 2019 Mar;8(1):1-8. Epub 2019 Jan 21. PMID: 31565541; PMCID: PMC6764767.
Copy Download .nbib Format: NLM
Fertility Preservation for Prepubertal Girls: Update and Current Challenges.

Current obstetrics and gynecology reports

Resetkova N, Hayashi M, Kolp LA, Christianson MS.
PMID: 25110617
Curr Obstet Gynecol Rep. 2013 Dec 01;2(4):218-225. doi: 10.1007/s13669-013-0060-9.

With increasing rates of diagnosis of childhood cancers and the evolution of more effective treatment options resulting in prolonged life spans, fertility preservation counseling is an integral component of the discussion at the time of diagnosis of childhood cancers....

Cite
Resetkova N, Hayashi M, Kolp LA, et al. Fertility Preservation for Prepubertal Girls: Update and Current Challenges. Curr Obstet Gynecol Rep. 2013;2(4):218-225doi: 10.1007/s13669-013-0060-9.
Resetkova, N., Hayashi, M., Kolp, L. A., & Christianson, M. S. (2013). Fertility Preservation for Prepubertal Girls: Update and Current Challenges. Current obstetrics and gynecology reports, 2(4), 218-225. https://doi.org/10.1007/s13669-013-0060-9
Resetkova, Nina, et al. "Fertility Preservation for Prepubertal Girls: Update and Current Challenges." Current obstetrics and gynecology reports vol. 2,4 (2013): 218-225. doi: https://doi.org/10.1007/s13669-013-0060-9
Resetkova N, Hayashi M, Kolp LA, Christianson MS. Fertility Preservation for Prepubertal Girls: Update and Current Challenges. Curr Obstet Gynecol Rep. 2013 Dec 01;2(4):218-225. doi: 10.1007/s13669-013-0060-9. PMID: 25110617; PMCID: PMC4125124.
Copy Download .nbib Format: NLM
Ethical and Psychosocial Impact of Female Infertility.

Current obstetrics and gynecology reports

Leyser-Whalen O, Temple JR, Phelps JY.
PMID: 23336092
Curr Obstet Gynecol Rep. 2012 Dec 01;1(4):153-158. doi: 10.1007/s13669-012-0023-6.

This manuscript reviews research from the past year on the ethical and psychosocial impact of infertility on women and men. We discuss several issues surrounding ovarian stimulation, particularly high-order multiple births, egg banking (especially for research purposes), and diminished...

Cite
Leyser-Whalen O, Temple JR, Phelps JY. Ethical and Psychosocial Impact of Female Infertility. Curr Obstet Gynecol Rep. 2012;1(4):153-158doi: 10.1007/s13669-012-0023-6.
Leyser-Whalen, O., Temple, J. R., & Phelps, J. Y. (2012). Ethical and Psychosocial Impact of Female Infertility. Current obstetrics and gynecology reports, 1(4), 153-158. https://doi.org/10.1007/s13669-012-0023-6
Leyser-Whalen, Ophra, et al. "Ethical and Psychosocial Impact of Female Infertility." Current obstetrics and gynecology reports vol. 1,4 (2012): 153-158. doi: https://doi.org/10.1007/s13669-012-0023-6
Leyser-Whalen O, Temple JR, Phelps JY. Ethical and Psychosocial Impact of Female Infertility. Curr Obstet Gynecol Rep. 2012 Dec 01;1(4):153-158. doi: 10.1007/s13669-012-0023-6. PMID: 23336092; PMCID: PMC3547399.
Copy Download .nbib Format: NLM
Male Hormonal Contraception: Where Are We Now?.

Current obstetrics and gynecology reports

Wang C, Festin MP, Swerdloff RS.
PMID: 26949570
Curr Obstet Gynecol Rep. 2016;5:38-47. doi: 10.1007/s13669-016-0140-8. Epub 2016 Jan 29.

Hormonal male contraception clinical trials began in the 1970s. The method is based on the use of exogenous testosterone alone or in combination with a progestin to suppress the endogenous production of testosterone and spermatogenesis. Studies using testosterone alone...

Cite
Wang C, Festin MP, Swerdloff RS. Male Hormonal Contraception: Where Are We Now?. Curr Obstet Gynecol Rep. 2016;5:38-47doi: 10.1007/s13669-016-0140-8.
Wang, C., Festin, M. P., & Swerdloff, R. S. (2016). Male Hormonal Contraception: Where Are We Now?. Current obstetrics and gynecology reports, 538-47. https://doi.org/10.1007/s13669-016-0140-8
Wang, Christina, et al. "Male Hormonal Contraception: Where Are We Now?." Current obstetrics and gynecology reports vol. 5 (2016): 38-47. doi: https://doi.org/10.1007/s13669-016-0140-8
Wang C, Festin MP, Swerdloff RS. Male Hormonal Contraception: Where Are We Now?. Curr Obstet Gynecol Rep. 2016;5:38-47. doi: 10.1007/s13669-016-0140-8. Epub 2016 Jan 29. PMID: 26949570; PMCID: PMC4762912.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 34 entries